Medicamen Biotech Ltd
BSE:
NSE:MEDICAMEQ
MEDICAMEQ Share Price
BSE:
NSE:MEDICAMEQ
Pharmaceuticals
Small Cap
₹-
0 (0%)
Market Cap
₹695.81Cr
PE Ratio
82.79
Medicamen Biotech Ltd Performance
▲
▲
▲
▲
Medicamen Biotech Ltd Fundamentals
Medicamen Biotech Ltd Delivery and Volume
About Medicamen Biotech Ltd
A diversified enterprise, Medicamen Biotech Limited (MBL) is a research-led pharmaceutical company involved in developing, manufacturing and marketing of finished dosage formulations for domestic as well as international markets. The Company has presence in 40+ countries. Its offerings include Finis
| Name | Designation |
|---|---|
| Sanjay Bansal | Non Executive Director |
| Rahul Bishnoi | Chairman (Non-Executive) |
| Ashwani Kumar Sharma | Non Executive Director |
| Harish Pande | Independent Director |
| S K Singh | Non Executive Director |
| Arun Kumar | Independent Director |
| Parul Choudhary | Company Sec. & Compli. Officer |
| Sumita Dwivedi | Independent Director |
| Vimal Kumar Shrawat. | Non Executive Director |
| Sangeeta Bishnoi | Independent Director |
| Ravi Kumar Bansal | Independent Director |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
Medicamen Biotech Ltd FAQs
How do I Buy Medicamen Biotech Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Medicamen Biotech Ltd shares in BlinkX.
What is the Share Price of Medicamen Biotech Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Medicamen Biotech Ltd's share price is ₹551.95 as of 2025-02-22.
What is the PE ratio of Medicamen Biotech Ltd?
Medicamen Biotech Ltd's P/E ratio is 82.79 times as of 2025-02-22.
What is the PB ratio of Medicamen Biotech Ltd?
Medicamen Biotech Ltd's most recent financial reports indicate a price-to-book ratio of 3.22, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Medicamen Biotech Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Medicamen Biotech Ltd's market capitalization is ₹695.81 Cr as on 2025-02-22.
What is the ROE of Medicamen Biotech Ltd?
The current financial records of Medicamen Biotech Ltd show a 6.6% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Medicamen Biotech Ltd?
According to Medicamen Biotech Ltd's most recent financial filings, the company has a total asset value of ₹154.87, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Medicamen Biotech Ltd?
The 52-week high/low price of a Medicamen Biotech Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Medicamen Biotech Ltd's 52-week high and low as of 2025-02-22 are ₹560.7 and ₹504.6, respectively.
